part of our structure-activity relationship studies, we report here the synthesis and in vitro anti-HBV and anti-HCV activities of a number of ring-expanded ('fat') nucleobases containing the imidazo[4,5-e][1,3]diazepine-4,8-dione ring system. One of the compounds, ZP-88, exhibited a good activity/toxicity profile against HBV by inhibition of the synthesis of extracellular virion release (EC(50)=1.7microM
作为我们的结构-活性关系研究的一部分,我们在这里报告许多含有
咪唑[4,5-e] [ 1,3]二氮杂-4,8-二酮环系统。其中一种化合物ZP-88通过抑制细胞外病毒体释放的合成(
EC(50)= 1.7microM,CC(50)= 286microM,SI = 168)和细胞内HBV表现出良好的针对HBV的活性/毒性复制的中间体(
EC(50)= 8.4microM,CC(50)= 286microM,SI = 34)在培养的人类肝母细胞瘤2.2.15细胞中。相比之下,大多数抗HCV的化合物仅具有边缘活性/毒性特征,尽管仍比参考化合物
利巴韦林更好。